Logo

Mission Bio Pharma Assay Development Services for Solid Tumor Research

Jul 12, 2022

Mission Bio has launched services for solid tumor assays through its Pharma Assay Development business. The services use the firm's Tapestri platform and single-cell solid tumor solution to provide high-resolution data on genetic diversity across cell populations and insights into the clonal landscape and co-occurrence of mutations. Mission Bio said that it offers pharma partners access to a dedicated team to develop assays, identify high-impact samples, and analyze data.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find structural network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.